129 related articles for article (PubMed ID: 3110778)
21. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
22. Transforming activity of DNA from rat liver tumors induced by the carcinogen methyl(acetoxymethyl)nitrosamine.
Goyette M; Dolan M; Kaufmann W; Kaufman D; Shank PR; Fausto N
Mol Carcinog; 1988; 1(1):26-32. PubMed ID: 2855600
[TBL] [Abstract][Full Text] [Related]
23. [Mutations in the 61st codon of the c-Ki-ras oncogene during transplacental lung tumor induction in mice and their difference in spontaneous and induced tumors].
Loktionov AS
Mol Biol (Mosk); 1991; 25(6):1517-25. PubMed ID: 1813798
[TBL] [Abstract][Full Text] [Related]
24. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
25. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
[TBL] [Abstract][Full Text] [Related]
26. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW
Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892
[TBL] [Abstract][Full Text] [Related]
27. Mutations in the Ha-ras proto-oncogene in spontaneous and chemically induced liver tumours of the CF1 mouse.
Bauer-Hofmann R; Buchmann A; Wright AS; Schwarz M
Carcinogenesis; 1990 Oct; 11(10):1875-7. PubMed ID: 2119910
[TBL] [Abstract][Full Text] [Related]
28. Activation of human c-raf-1 by replacing the N-terminal region with different sequences.
Tahira T; Ochiai M; Hayashi K; Nagao M; Sugimura T
Nucleic Acids Res; 1987 Jun; 15(12):4809-20. PubMed ID: 2955285
[TBL] [Abstract][Full Text] [Related]
29. Expression of the c-Ha-ras and c-myc genes in aflatoxin B1-induced hepatocellular carcinomas.
Tashiro F; Morimura S; Hayashi K; Makino R; Kawamura H; Horikoshi N; Nemoto K; Ohtsubo K; Sugimura T; Ueno Y
Biochem Biophys Res Commun; 1986 Jul; 138(2):858-64. PubMed ID: 3017342
[TBL] [Abstract][Full Text] [Related]
30. Characterization of mutagen-activated cellular oncogenes that confer anchorage independence to human fibroblasts and tumorigenicity to NIH 3T3 cells: sequence analysis of an enzymatically amplified mutant HRAS allele.
Stevens CW; Manoharan TH; Fahl WE
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3875-9. PubMed ID: 3131765
[TBL] [Abstract][Full Text] [Related]
31. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
Schmeiser HH; Janssen JW; Lyons J; Scherf HR; Pfau W; Buchmann A; Bartram CR; Wiessler M
Cancer Res; 1990 Sep; 50(17):5464-9. PubMed ID: 2201437
[TBL] [Abstract][Full Text] [Related]
32. Transforming DNA sequences present in human prolactin-secreting pituitary tumors.
Gonsky R; Herman V; Melmed S; Fagin J
Mol Endocrinol; 1991 Nov; 5(11):1687-95. PubMed ID: 1779971
[TBL] [Abstract][Full Text] [Related]
33. A c-ras-Ki oncogene is activated, amplified and overexpressed in a human osteosarcoma cell line.
Nardeux PC; Daya-Grosjean L; Landin RM; Andéol Y; Suàrez HG
Biochem Biophys Res Commun; 1987 Jul; 146(2):395-402. PubMed ID: 3476115
[TBL] [Abstract][Full Text] [Related]
34. B-raf and Ha-ras mutations in chemically induced mouse liver tumors.
Jaworski M; Buchmann A; Bauer P; Riess O; Schwarz M
Oncogene; 2005 Feb; 24(7):1290-5. PubMed ID: 15592514
[TBL] [Abstract][Full Text] [Related]
35. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
36. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
37. N-ras mutation in ultraviolet radiation-induced murine skin cancers.
Pierceall WE; Kripke ML; Ananthaswamy HN
Cancer Res; 1992 Jul; 52(14):3946-51. PubMed ID: 1617670
[TBL] [Abstract][Full Text] [Related]
38. Activation of the K-ras protooncogene in lung tumors from rats and mice chronically exposed to tetranitromethane.
Stowers SJ; Glover PL; Reynolds SH; Boone LR; Maronpot RR; Anderson MW
Cancer Res; 1987 Jun; 47(12):3212-9. PubMed ID: 3581065
[TBL] [Abstract][Full Text] [Related]
39. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
Wang Y; Wang Y; Stoner G; You M
Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
[TBL] [Abstract][Full Text] [Related]
40. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.
Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW
Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
